⌘K

Login Start Free

Home/Filings/4/0001447348-13-000027

4//SEC Filing

PROGENICS PHARMACEUTICALS INC 4

Accession 0001447348-13-000027

CIK 0000835887operating

View on SEC.gov Company Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 3:44 PM ET

Size

5.0 KB

Accession

0001447348-13-000027

Insider Transaction Report

Form 4

Period: 2013-06-12

PROGENICS PHARMACEUTICALS INCPGNX

Chief Executive Officer/CSO10% Owner

Transactions

Award
Non-Qualified Stock Option (right to buy)
2013-06-12$4.76/sh+20,000$95,200→ 20,000 total
Exercise: $4.76From: 2013-06-12Exp: 2023-06-12→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]This stock option becomes exercisable immediately, on the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000835887

Filing Metadata

Form type: 4
Filed: Jun 19, 8:00 PM ET
Accepted: Jun 20, 3:44 PM ET
Size: 5.0 KB

View on SEC.gov